The biochemical profiles obtained with Staph-Ident (Analytab Products, Plainview, N.Y.) panels were combined with' the results of adherence and synergistic hemolysis tests to define biotypes among 1,064 clinical isolates representing eight species of coagulase-negative staphylococci. The 672 isolates of Staphylococcus epidermidis were aligned in 69 of 144 potential biotypes in our scheme because of 18 different biochemical profiles and the eight physiologic subtypes. Isolates of most other species were in fewer biotypes because of more uniform adherence and synergistic hemolysis datà, as well as fewer biochemical profiles. Since adherence and synergistic hemolysis may prove to be related to virulence and pathogenicity, biotyping with these test results would help evaluate the reliability of adherence and synergistic hemolysis as possible indices of the clinical significance of some of these organisms. When the antimicrobial susceptibility and plasmid profiles obtained on two clusters of S. epidermidis isolates were compared with the biotyping results, one cluster was not further differentiated by plasmid profiles, but was by antimicrobial profiles; the other cluster with only two biotypes was further divided into five distinct types by plasmid profiles but was not separated at all by antimicrobial profiles.
The natural habitats of Staphylococcus epidermidis and several other species of coagulase-negative staphylococci include the skin and nares (11) ; a clinical specimen could, therefore, contain both contaminants and pathogens of these species. If a contaminant is mistakenly identified as a pathogen, i.e., the source of the isolate was the skin and not an infective process, the patient will probably receive unneeded antimicrobial therapy. When coagulase-negative staphylococci are isolated from a specimen, particularly one obtained by skin puncture, their significance is often doubted and two questions are often asked. Is the isolate a potential pathogen, and is it identical to skin isolates? Furthermore, the question of whether strains are identical may be raised when more than one isolate of coagulase-negative staphylococci is obtained from a specimen, particularly from blood cultures. These considerations have become more critical since coagulase-negative staphylococci have become one of the most frequent causes of nosocomial infections (9) .
One way to approach the question of whether strains are identical is to use a biotyping scheme. The biochemical profiles obtained with the Staph-Ident system (Analytab Products, Plainview, N.Y.) have been combined with antibiograms, slime production, and phage types to identify strains in epidemiologic investigations; plasmid banding patterns have been used to differentiate strains of S. epidermidis (17) and to enhance epidemiologic studies (16, 18) . One test that has been prominently proposed as a tool for measuring the clinical significance of coagulase-negative staphylococci (3, 4, 10) is slime production or adherence (2) , but tests for exotoxin production or synergistic hemolysis (8) have also been suggested. If these characteristics are considered to be indicators of pathogenicity, the biotyping scheme that included them could serve a dual purpose: to type the isolates and to determine their clinical significance.
In a companion report (7) , we presented the results of biochemical studies, adherence tests, and synergistic hemolysis tests of a large collection of coagulase-negative * Corresponding author.
staphylococci. We reexamined those data to see whether they could be used to differentiate strains for epidemiologic studies. The result was to combine data from several test systems into a biotyping scheme. In this report, we define our biotyping scheme, show its application to our culture collection, and discuss its use with plasmid and antimicrobial profiles on two small clusters of S. epidermidis isolates.
MATERIALS AND METHODS
Cultures and growth conditions. All of the isolates examined for this study were part of a larger collection of strains described in the companion report (7) . A total of 1,064 of those clinical isolates (7) were included in this biotyping study; these included 672 S. epidermidis, 133 S. haemnolyticus, 103 S. hominis, 48 S. simulans, 38 S. saprophyticus, 40 S. warneri, 15 S. capitis, and 15 S. xylosus. Five of the S. epidermidis isolates were from the cardiac-care wing of hospital A; four of the five came from pump blood collected in the operating room from heart-lung bypass machines, and the fifth came from a blood culture taken 6 days postoperation from one of the four patients. Seven other S. epidermidis isolates were from multiple blood cultures taken from a single patient who had pneumonia and a cardiac murmur at hospital B. All of the cultures were grown on Trypticase soy agar containing 5% defibrinated sheep blood (TSA II; BBL Microbiology Systems, Cockeysville, Md.) and were incubated aerobically for 18 to 24 h at 35°C. details of the qualitative procedure we used were discussed in the companion report (7 Antimicrobial profiles. The 12 S. epidermidis isolates from hospitals A and B were tested for susceptibility to a set of 13 antimicrobial agents by agar disk diffusion as described previously (14) . The antibiotic disks (BBL) used were penicillin (10 U), oxacillin (1 ,ug) , methicillin (5 ,ug) , amoxicillinclavulanate (20/10 ,ug) , cephalothin (30 ,ug) , erythromycin (15 ,ug) , clindamycin (2 ,ug) , chloramphenicol (30 ,ug), tetracycline (30 ,ug), sulfamethoxazole-trimethoprim (23.75/1.25 ,ug), rifampin (5 ,ug) , vancomycin (30 ,ug), and gentamicin (10 itg).
P-Lactamase test. The same 12 isolates were also examined for P-lactamase production by a rapid chromogenic cephalosporin test (15, 20) . A 500-,ug/ml solution of nitrocefin (Glaxo, Ltd., Greenford, Middlesex, England) was prepared by dissolving 20 ,-lactamase-negative strains of S. aureus were included as controls. Independent testing and data analysis. The plasmid studies were done by two of us, and the antimicrobial susceptibility studies were done by another one of us independent of any other analyses. All data except the plasmid and antimicrobial results were stored and analyzed with computer software (dBASE III PLUS; Ashton-Tate, Torrance, Calif.) and a portable computer (COMPAQ) upgraded to 640 kilobytes (7) .
RESULTS
A summary of the Staph-Ident, adherence, and synergistic hemolysis test results is shown in Table 1 . The isolates in each of these eight species of coagulase-negative staphylococci gave at least five different profiles with the Staph-Ident system, and within each species some of the profiles were unique. This was most striking among isolates of S. xylosus, because those 15 isolates gave 12 different biochemical profiles, and only 2 of those profiles were produced by more than 1 isolate. Because the distribution of several biochemical profiles within each species seemed a good basis for an initial separation into biotypes, the biochemical profiles obtained with the Staph-Ident system for each species were listed in the order of frequency of occurrence and were assigned letter codes for biotyping (leaving out O and Q to avoid confusion).
In the adherence test, 42 to 83% of the isolates in six of the eight species were positive. In addition, the adherencepositive isolates were graded as strong, moderate, or weak (7) . Among the 747 adherence-positive isolates in these eight species, 29% were strongly positive, 55% were moderately positive, and 16% were weakly positive. Most (200 of 214) of the strongly positive isolates among these species were S. epidermidis; however, among the 556 adherence-positive S. epidermidis isolates, 36% were strong, 50% were moderate, and 14% were weak. These adherence test results suggest that this test can be used for the subtyping of isolates.
The synergistic hemolysis test results showed homogeneity within four of these species; none of the S. saprophyticus were positive; and nearly all the S. haemolyticus (99%), S. simulans (96%), and S. capitis (93%) isolates were positive. Among the other four species, however, 52 to 73% of the isolates were positive. With this range of values, synergistic hemolysis could also be a tool for subtyping isolates. Therefore, the physiologic subtypes for biotyping were defined by the results obtained with the adherence and synergistic hemolysis tests ( Isolates were seen in each of the eight possible subtypes of biotypes A, B, and C; seven subtypes of biotype D; six subtypes of biotype E; and five subtypes of biotype F. In the biotypes G through R that contained more than one isolate, the subtypes gave many unique codes that represented single isolates.
The many biotypes and subtypes among the other seven species of coagulase-negative staphylococci are shown in Table 4 . The Staph-Ident profiles obtained with the 103 isolates of S. hominis were contained in five profiles, but 100 (97%) were in one of three profiles: 2000 (36%), 2400 (31%), and 2040 (30%). The data on S. hominis showed a nearly even distribution of strains among the subtypes in the three major biotypes. As expected, only two subtypes per species were useful in separating the isolates within most of the other species. Most of the isolates of S. haemolyticus and S. simulans were in subtypes 1 and 3, because isolates in these species are rarely negative in synergistic hemolysis tests. All of the isolates of S. saprophyticus were in subtypes 2 and 4, because isolates of this species do not exhibit synergistic hemolysis; and most of the isolates of S. warneri were in subtypes 3 and 4, because adherence is seldom, if ever, seen among isolates of this species. The data on adherence classes are not shown for these seven species; but they were very useful in separating the subtype 1 isolates of S. hominis, S. haemolyticius, and S. simulans and the subtype 2 isolates of S. hominis.
The electrophoretograms obtained during the plasmid studies are shown as Fig. 1 and 2 . The profile in lane 1 on each gel and all similar profiles on that gel within that set of isolates were given the code letter A; the next profile encountered was designated B, and so on, until all profiles for a given set of isolates were assigned a code.
There were three different plasmid profiles among the five isolates from hospital A (Fig. 1) . Isolates 1 and 3 with profile A contained one large plasmid band and several smaller bands that were not seen in the other three isolates. Profile B of isolate 2 also contained several bands, but it was unique among these five isolates. Although the profiles of isolates 4 and 5 were slightly different, each was designated a separate subtype of profile C because of the possible loss in isolate 4 of the large plasmid seen in isolate 5.
There were five different plasmid profiles among the seven isolates from hospital B (Fig. 2) . Isolates 1, 2, and 4 had identical banding patterns; but the other four isolates had profiles different from these and from each other.
The disk-diffusion antimicrobial susceptibility profiles obtained with the five isolates from hospital A are shown in Table 5 . The profile of isolate 1, and any similar profile in this set of five isolates, was assigned the code letter A; the next profile encountered was assigned the letter B, and so on until all profiles were assigned codes. Isolates 1, 2, and 3 were resistant to six or seven of the antibiotics tested. Isolates 1 and 3 of profile A were identical, including their mixed sulfamethoxazole-trimethoprim test results; each produced a zone of susceptibility with this disk, but both zones contained several discrete colonies that indicated some resistance to this drug. Isolate 2 was the only one that was resistant to tetracycline and gentamicin and was assigned profile B. Isolates 4 and 5 were very susceptible and quite different from the other three in this set; isolate 4 was 1-lactamase positive and resistant to penicillin only, but isolate 5 was 1-lactamase negative and susceptible to all of the antibiotics tested, so they were assigned to separate profiles (C and D, respectively). The susceptibility data for the isolates from hospital B are not shown, because they all had the same antimicrobial profile. All seven isolates from hospital B were P-lactamase positive and resistant to penicillin but were susceptible to the other 12 antibiotics tested.
The combined data on the two clusters of S. epidermidis isolates are shown in Table 6 . The test results that produced the biotype codes are included in Table 6 to illustrate the conversion of data to code. There were three different biotypes among the five isolates from hospital A. Isolates 1, Table 6 . All were strongly positive in the adherence 4 test, but there were two distinct biotypes among these seven isolates because of the results of the Staph-Ident and synergistic hemolysis tests. The five isolates in biotype A2a did not exhibit synergistic hemolysis, but the two isolates in biotype Fla were positive for synergistic hemolysis. Both of the biotypes among these seven isolates were further separated by the plasmid profiles; biotype A2a included three different plasmid profiles (A, B, and E), and biotype Fla included two plasmid profiles (C and D). The antimicrobial profiles for these isolates were identical and, therefore, did not separate the isolates at all. These seven isolates were all from the same patient.
DISCUSSION
The Staph-Ident system gives good correlation with conventional methods (12) for species identification of clinical isolates of staphylococci (7, 13) . This rapid, 10-test system, although designed to identify species of staphylococci, has also been used to biotype strains within species of coagulasenegative staphylococci (1, 18) . The biochemical characteristics of these organisms are diverse enough for several profiles to define the same species correctly. The biochemical profiles then can also serve as a means of differentiating strains within the same species. In most studies, however, too few profiles were seen per species to be very helpful in epidemiologic studies; therefore, the Staph-Ident system was used with other tests to define subtypes for greater discrimination. Some of the other tests used were antimicrobial susceptibilities, serotyping, phage typing, plasmid profiles, and slime production or adherence (16) .
We also used the biochemical profiles of Staph-Ident to define our biotypes, but we supplemented them with two physiologic tests, adherence and synergistic hemolysis, to define four subtypes and then further separated two of the subtypes with three classes each of adherence. Although we could have separated the other two subtypes with three classes each of synergistic hemolysis, i.e., weak, moderate, or strong, we felt that that degree of separation could best be used on a smaller, specific set of strains with a specific lot of media.
One of the newer tools for differentiating strains or determining their relatedness is the plasmid profile. The current methods are complex enough that they are not practical for the routine examination of large groups of strains, nor are they methods that are likely to be used by most clinical laboratories, but the determination of plasmid profiles may prove to be valuable in special situations. Perhaps the best use of this technique is the study of a given subset of strains from the same outbreak or patient that appear identical by all of the other test systems. The two clusters of S. epidermidis isolates examined during this study were examples of this: (i) a set of isolates from a clinic where pump blood was questioned as the source of a patient's infection and (ii) a set of isolates from a single patient whose physician questioned whether all of the isolates were the same strain. In the first cluster, biotyping alone showed that the pump blood isolates were not identical to the isolate from the patient, and the plasmid profiles did not give any further differentiation. In the second cluster, however, biotyping defined only two groups of isolates, but the plasmid studies yielded five distinct profiles that showed that no more than three of the seven isolates were the same strain.
Both the adherence test and the synergistic hemolysis test have given reproducible results in our laboratory when the tests were done exactly as described previously (7, 8) . One of the problems encountered when attempting to use plasmid profiles to characterize a set of strains, however, is the (7, 8) . Other cytolytic and equally destructive biologic activities may occur in vivo as a result of adherence and synergism. In a recent review, Gemmell (5) discussed the production of these and other toxins and enzymes by coagulase-negative staphylococci and concluded that we need more detailed investigations of natural and experimental infection before we can determine the role (if any) of the many virulence factors that have been postulated for these organisms. We suggest, therefore, that a biotyping scheme that includes tests for adherence and synergistic hemolysis be applied to collections of isolates with sufficient clinical data to evaluate the reliability of these two characteristics as possible measures of significance. We also suggest that the system we have proposed for biotyping will be useful but recognize that this must be confirmed by applying it to a sufficient and significant body of clinical data.
